FuXion has experienced 300% growth, closing out 2014 at the $80 million mark.
The forecast for 2015 is to continue the expansion of the company in North and Central America.
In addition to fantastic leadership, the FuXion difference is the quality of the product, the cost-benefits, technology, and a passion for science.
“My passion was always focused on the development of the products. We have invested a lot of time, effort and money to ensure we have an array of products that cover many of the aspects of physical health and we still have much to do.
However, I have discovered an even greater passion for transformation, through true health.
We have transformed lives of businessmen, entrepreneurs, distributors, families, regions; and we will not stop until we have achieved a positive transformation of this continent, and our world”, said Alvaro Zúñiga, FuXion’s CEO.
Mr. Zúñiga went on to say, “FuXion stands for nutraceutical fusion, which is the combination of cutting edge biotechnology with ingredients and active substances of millenary Andean, Mesoamerican and Asian cultures. We have more than 1500 bioactive principals and 5 patents, the most important being BioProtein+ with colostrum.
With this fusion of our passion for scientific product development, incredible price